Reaction profile

The FDA adverse-event record for lymphangiectasia

Name: Lymphangiectasia - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

10 FDA reports name lymphangiectasia, a lower-volume reaction in the CVM extract (VeDDRA 2348). Plate stamps and neighbourhood peers follow.

#2461 of 2,481
by report volume (all reactions): 10
reports citing this reaction: 10.0%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

FDA AER · VeDDRA plate

Code 2348 VOL-TRACE

VOL-TRACE · DEATH-ELEV · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-MID · BOOK-FULL

VOL-TRACE 10 reports
DEATH-ELEV 10.0%
BOTTOM-DECILE #2461/2481
PHOTO-FINISH Anoxia
SPECIES-DOG Dog · 10
DRUG-LEAD Fluralaner 13.64%… · 2
DESK-MID 5 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Anoxia (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Lymphangiectasia

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Lymphangiectasia

What the FDA AER plate says about Lymphangiectasia

Signature read: 10 reports place Lymphangiectasia in the lower third of FDA AER volume (#2461 of 2,481). Report volume is lower-third scale: 10 named reports in the openFDA extract. 1 of 10 reports were death-coded (10.0% of named reports, not a population mortality rate). Nearest volume peer: Anoxia (±0 reports). Lead species Dog (10). Lead co-reported drug Fluralaner 13.64% 12-Week Chew (2).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Fluralaner 13.64% 12-Week Chew appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 10

Breeds Most Affected

Retriever - Labrador 4

Boxer (German Boxer) 2

Setter (unspecified) 2

Crossbred Canine/dog 1

Bichon Frise 1

Associated Drugs

Fluralaner 13.64% 12-Week Chew 2

Bedinvetmab 2

Oclacitinib Maleate 2

Milbemycin Oxime, Praziquantel 1

Fluralaner 1

Unspecified Lyme Vaccine 1

Anti-Diarrheal Supplement 1

Probiotics 1

Trilostane 1

Liver Supplement 1

Maropitant Citrate 1

Gabapentin 1

Low Fat Food 1

Fluids 1

Denamarin 1

Vitamin B12 1

Herbal Supplement 1

Tigilanol Tiglate 1

Grapiprant 1

Lotilaner 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Lymphangiectasia (#2461 of 2,481 by report volume); death-coded 10.0%. PlainBreed reaction plate · report volume stamp 10 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →